熱門資訊> 正文

Edwards Lifesciences任命新首席财务官

2026-05-05 04:53

Edwards Lifesciences (EW) appointed Theodora Mistras as chief financial officer effective end of May 2026.
Mistras joins from Viatris (VTRS), where she served as CFO since 2024.
She succeeds Scott Ullem, who is transitioning after over a decade in the role.
Mistras brings extensive experience in healthcare finance, including roles at Citigroup Global Markets and Goldman Sachs.

More on Edwards Lifesciences

Edwards Lifesciences Corporation (EW) Q1 2026 Earnings Call Transcript
Edwards Lifesciences: More Appeal For The Heart
Edwards Lifesciences Corporation (EW) Presents at Leerink Global Healthcare Conference 2026 Transcript
Edwards forecasts 9%-11% 2026 sales growth and $2.95-$3.05 adjusted EPS as TAVR guide rises to 7%-9%
Edwards Lifesciences raises 2026 revenue guidance on bullish Q1 results

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。